XWAR
VOX
Market cap393mUSD
Oct 09, Last price
145.20PLN
1D
-1.76%
1Q
29.64%
Jan 2017
669.07%
IPO
916.10%
Name
Voxel SA
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Voxel S.A. manages an extensive chain of facilities dedicated to diagnostic medical imaging. The company's offerings encompass a broad range of advanced imaging services, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), and single photon emission computed tomography (SPECT). Furthermore, Voxel S.A. provides teleradiology and outsourcing solutions within the diagnostic imaging sector, alongside developing information systems specifically designed for hospitals and diagnostic centers. The firm also undertakes ventures focused on equipping and implementing new diagnostic laboratories. Established in 2005 and headquartered in Kraków, Poland, Voxel S.A. maintains its operational presence through 33 specialized laboratories situated in 21 Polish cities.
Related entities
Subsidiaries
Alteris Spolka Akcyjna
Key people
Magdalena Kowalska
Chief Accounting Officer
Vladimir Jezik
Member of the Supervisory Board · since 2018
Jakub Kowalik
Member of the Supervisory Board · since 2016
Martyna Liszka
Member of the Supervisory Board · since 2016
Magdalena Pietras
Member of the Supervisory Board · since 2016
Member of the Supervisory Board · since 2017
Legal address
KRAKÓW WIELICKA 265
KRAKÓW, 12 30-663
PL
KRAKÓW, 12 30-663
PL
Headquarters
KATOWICE CEGLANA 35
KATOWICE, 24 40-514
PL
KATOWICE, 24 40-514
PL
Valuation
Title PLN in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||